From:Melissa Hope
Date:September 13, 2005 11:48:42 AM EDT
To:bmcserieseditor@biomedcentral.com, editorial@biomedcentral.com, info@biomedcentral.com
Cc:Lori Heise , brachlis@ccnm.edu, Kumanan.Wilson@uhn.on.ca, sosingh@jhsph.edu, pwu@ccnm.edu, elainem.wong@gmail.com, emills@ccnm.edu
Subject:Letter in response to Mills et al's "Media reporting of tenofovir trials in Cambodia and Cameroon"
To the editor:
Mills et al("Media reporting of tenofovir trials in Cambodia and Cameroon" BMC International Health and Human Rights 2005, 5:6, 24 August 24, 2005) claim in their first sentence that PREP trials were "closed due to activist pressure on host country governments". Activists worked to improve trial conditions, which would have been a real victory. The reason these trials were closed was that researchers did not meet with or meet the needs of participants. This lack of engagement with participants is why participants became activists and reached out to their international support networks and the media.